ATCC Receives New CDC Award to Help Fast-track Diagnostic Tests for Future Disease Outbreaks
ATCC secures a new CDC award to fast‑track scalable diagnostic tests and strengthen U.S. preparedness for future disease outbreaks.
ATCC Secures NIAID Contract to Strengthen U.S. Preparedness Against Emerging Infectious Diseases
ATCC expands its partnership with NIAID, advancing U.S. readiness against emerging infectious diseases through enhanced testing and assay development.
ATCC Expands Role in Supporting the NIST's Monoclonal Antibody Reference Materials
ATCC expands its collaboration with NIST to deliver trusted monoclonal antibody reference materials that strengthen reproducibility and accelerate therapeutic innovation.